JP2014531205A5 - - Google Patents

Download PDF

Info

Publication number
JP2014531205A5
JP2014531205A5 JP2014530196A JP2014530196A JP2014531205A5 JP 2014531205 A5 JP2014531205 A5 JP 2014531205A5 JP 2014530196 A JP2014530196 A JP 2014530196A JP 2014530196 A JP2014530196 A JP 2014530196A JP 2014531205 A5 JP2014531205 A5 JP 2014531205A5
Authority
JP
Japan
Prior art keywords
sequence
polypeptide
seq
glycoprotein
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014530196A
Other languages
English (en)
Japanese (ja)
Other versions
JP6076349B2 (ja
JP2014531205A (ja
Filing date
Publication date
Priority claimed from GB201115841A external-priority patent/GB201115841D0/en
Application filed filed Critical
Publication of JP2014531205A publication Critical patent/JP2014531205A/ja
Publication of JP2014531205A5 publication Critical patent/JP2014531205A5/ja
Application granted granted Critical
Publication of JP6076349B2 publication Critical patent/JP6076349B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014530196A 2011-09-13 2012-09-12 ストレプトコッカス・ピオゲネス由来のエンドグリコシダーゼ及びその使用方法 Active JP6076349B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB201115841A GB201115841D0 (en) 2011-09-13 2011-09-13 Protein and method
GB1115841.7 2011-09-13
PCT/EP2012/067841 WO2013037824A1 (en) 2011-09-13 2012-09-12 Endoglycosidase from streptococcus pyogenes and methods using it

Publications (3)

Publication Number Publication Date
JP2014531205A JP2014531205A (ja) 2014-11-27
JP2014531205A5 true JP2014531205A5 (cg-RX-API-DMAC7.html) 2015-10-29
JP6076349B2 JP6076349B2 (ja) 2017-02-08

Family

ID=44908522

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014530196A Active JP6076349B2 (ja) 2011-09-13 2012-09-12 ストレプトコッカス・ピオゲネス由来のエンドグリコシダーゼ及びその使用方法

Country Status (20)

Country Link
US (1) US9493752B2 (cg-RX-API-DMAC7.html)
EP (1) EP2756077B1 (cg-RX-API-DMAC7.html)
JP (1) JP6076349B2 (cg-RX-API-DMAC7.html)
KR (1) KR102001427B1 (cg-RX-API-DMAC7.html)
CN (1) CN103946377B (cg-RX-API-DMAC7.html)
AU (1) AU2012307461B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014005816A2 (cg-RX-API-DMAC7.html)
CA (1) CA2848230C (cg-RX-API-DMAC7.html)
DK (1) DK2756077T3 (cg-RX-API-DMAC7.html)
EA (1) EA028490B8 (cg-RX-API-DMAC7.html)
ES (1) ES2627334T3 (cg-RX-API-DMAC7.html)
GB (2) GB201115841D0 (cg-RX-API-DMAC7.html)
IL (1) IL231410A0 (cg-RX-API-DMAC7.html)
IN (1) IN2014CN02163A (cg-RX-API-DMAC7.html)
MX (1) MX347727B (cg-RX-API-DMAC7.html)
PL (1) PL2756077T3 (cg-RX-API-DMAC7.html)
PT (1) PT2756077T (cg-RX-API-DMAC7.html)
SG (1) SG11201400505YA (cg-RX-API-DMAC7.html)
WO (1) WO2013037824A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201401840B (cg-RX-API-DMAC7.html)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002216863B8 (en) * 2000-12-21 2008-03-20 Id Biomedical Corporation Streptococcus pyogenes antigens and corresponding DNA fragments
RS64329B1 (sr) 2012-10-23 2023-08-31 Synaffix Bv Modifikovano antitelo, konjugat antitela i postupak za njihovo pripremanje
WO2014177771A1 (en) 2013-05-02 2014-11-06 Glykos Finland Oy Conjugates of a glycoprotein or a glycan with a toxic payload
EP2935608A1 (en) 2013-10-14 2015-10-28 SynAffix B.V. Modified glycoprotein, protein-conjugate and process for the preparation thereof
EP3929301A1 (en) 2013-10-14 2021-12-29 SynAffix B.V. Glycoengineered antibody, antibody-conjugate and methods for their preparation
WO2015057064A1 (en) 2013-10-14 2015-04-23 Synaffix B.V. Modified glycoprotein, protein-conjugate and process for the preparation thereof
WO2015057065A1 (en) 2013-10-14 2015-04-23 Synaffix B.V. Glycoengineered antibody, antibody-conjugate and methods for their preparation
GB201318490D0 (en) * 2013-10-18 2013-12-04 Genovis Ab Method
EP3097079B1 (en) 2014-01-24 2021-05-12 SynAffix B.V. Process for the cycloaddition of a hetero(aryl) 1,3-dipole compound with a (hetero)cycloalkyne
CA2954934C (en) 2014-06-30 2023-09-26 Glykos Finland Oy Drug derivative and conjugates
GB201413240D0 (en) 2014-07-25 2014-09-10 Hansa Medical Ab Method
EP3177633B1 (en) 2014-08-04 2022-07-20 SynAffix B.V. Process for the modification of a glycoprotein using a beta-(1,4)-n-acetylgalactosaminyltransferase or a mutant thereof
GB201502306D0 (en) * 2015-02-12 2015-04-01 Hansa Medical Ab Protein
GB201502305D0 (en) * 2015-02-12 2015-04-01 Hansa Medical Ab Protein
JP6966162B2 (ja) 2015-04-23 2021-11-10 シンアフィックス ビー.ブイ. β(1,4)−N−アセチルガラクトサミニルトランスフェラーゼであるか又はそれに由来するグリコシルトランスフェラーゼを用いる糖タンパク質の改変方法
US11008601B2 (en) 2016-01-15 2021-05-18 University Of Maryland Endo-S2 mutants as glycosynthases, method of making and use for glycoengineering of glycoproteins
SG11201806639VA (en) * 2016-02-04 2018-09-27 Genovis Ab New streptococcal proteases
TWI727883B (zh) * 2016-08-24 2021-05-11 醣基生醫股份有限公司 利用醣苷內切酶突變體重塑醣蛋白及其使用方法
FI3630968T3 (fi) 2017-05-26 2024-07-24 Genovis Ab Entsyymejä glykaanien analysointiin
US20210228738A1 (en) 2017-07-17 2021-07-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins
CN112672764A (zh) 2018-06-19 2021-04-16 格莱科斯生物医药公司 结合物
CN112672765A (zh) 2018-06-29 2021-04-16 格莱科斯生物医药公司 结合物
US20230038373A1 (en) 2019-12-18 2023-02-09 Glykos Biomedical Oy Stabile conjugate
CN111044731B (zh) * 2019-12-19 2021-05-07 北京科技大学 脉冲温育免疫反应分离富集多肽药物中肽类杂质的方法
WO2021142199A1 (en) 2020-01-09 2021-07-15 Mersana Therapeutics, Inc. Site specific antibody-drug conjugates with peptide-containing linkers
GB202002072D0 (en) * 2020-02-14 2020-04-01 Hansa Biopharma AB immunoglobulin detection and associated therapies
JP2023541698A (ja) * 2020-09-21 2023-10-03 上海宝済薬業有限公司 組合せ医薬及びその使用
TW202241954A (zh) 2021-01-04 2022-11-01 美商梅爾莎納醫療公司 靶向b7-h4之抗體-藥物共軛體和使用彼之方法
EP4079848A1 (en) 2021-04-22 2022-10-26 Genovis Ab Immunoglobulin cleaving enzyme
CN115873833B (zh) * 2022-11-08 2024-08-16 上海泰昶生物技术有限公司 生产免疫球蛋白g降解酶的工程菌株和工艺
CN117165643B (zh) * 2023-08-17 2025-10-28 山东大学 一种糖苷内切酶在水解高甘露糖型n-糖蛋白中的应用
WO2025098484A1 (zh) * 2023-11-10 2025-05-15 上海齐鲁制药研究中心有限公司 新型Endo S2突变体酶
WO2025180451A1 (zh) * 2024-03-01 2025-09-04 上海齐鲁制药研究中心有限公司 新型Endo S2突变体酶
WO2025248500A1 (en) 2024-05-31 2025-12-04 Janssen Biotech, Inc. Antibody drug conjugates that target enpp3

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130228D0 (en) 2001-12-18 2002-02-06 Hansa Medica Ab Protein
GB0624874D0 (en) * 2006-12-13 2007-01-24 Hansa Medical Ab Treatment
CN101889082A (zh) * 2007-09-14 2010-11-17 季诺维斯公司 用于解离Fcgamma-受体-IgG复合物以及纯化与检测IgG的方法和试剂盒
GB0821100D0 (en) 2008-11-18 2008-12-24 Hansa Medical Ab Antibodies
ES2528321T3 (es) * 2009-10-02 2015-02-06 Roche Glycart Ag Detección de a-fucosilación en anticuerpos

Similar Documents

Publication Publication Date Title
JP2014531205A5 (cg-RX-API-DMAC7.html)
MX348071B (es) Variantes de fc.
RU2018108836A (ru) ВАРИАНТЫ Fc И СПОСОБЫ ИХ ПОЛУЧЕНИЯ
JP2019506866A5 (cg-RX-API-DMAC7.html)
JP2015212284A5 (cg-RX-API-DMAC7.html)
WO2014118360A3 (en) Carbohydrate degrading polypeptide and uses thereof
JP2018537087A5 (cg-RX-API-DMAC7.html)
JP2016052331A5 (cg-RX-API-DMAC7.html)
EA201101553A1 (ru) Полипептид, деградирующий углеводы, и его применения
IL288541B (en) Vaccine against rsv
GB201115841D0 (en) Protein and method
WO2014202616A3 (en) Rasamsonia gene and use thereof
JP2015514811A5 (cg-RX-API-DMAC7.html)
WO2015086590A3 (en) A peptide mixture
JP2016501198A5 (cg-RX-API-DMAC7.html)
HK1248714A1 (zh) Ras蛋白的突变的片段
MX2019000903A (es) Metodos para purificar proteinas que contienen fc.
NZ742660A (en) Variants of chymosin with improved milk-clotting properties
MX340772B (es) Medios y metodos para fabricar neurotoxina altamente pura.
EP4374913A3 (en) Novel human serum albumin mutant
WO2014202622A3 (en) Rasamsonia gene and use thereof
JP2017505620A5 (cg-RX-API-DMAC7.html)
WO2010007144A3 (en) Mutated netrin-4 proteins, fragments thereof and their uses as drugs
JP2017538443A5 (cg-RX-API-DMAC7.html)
JP2014503216A5 (cg-RX-API-DMAC7.html)